Cited by 102Epilepsy research and treatmentIon channel regulation and functionCardiac electrophysiology and arrhythmias

Mutations in SCN3A cause early infantile epileptic encephalopathy

Open access
Zaman, Tariq, Helbig, Ingo, Božović, Ivana Babić, DeBrosse, Suzanne D., Bergqvist, A. Christina, Wallis, Kimberly, Medne, Livija, Maver, Aleš +4 more·2018·Annals of Neurology

Abstract

Objective: Voltage‐gated sodium (Na + ) channels underlie action potential generation and propagation and hence are central to the regulation of excitability in the nervous system. Mutations in the genes SCN1A, SCN2A , and SCN8A , encoding the Na + channel pore‐forming (α) subunits Nav1.1, 1.2, and 1.6, respectively, and SCN1B , encoding the accessory subunit β 1 , are established causes of genetic epilepsies. SCN3A , encoding Nav1.3, is known to be highly expressed in brain, but has not previously been linked to early infantile epileptic encephalopathy. Here, we describe a cohort of 4 patients with epileptic encephalopathy and heterozygous de novo missense variants in SCN3A (p.Ile875Thr in 2 cases, p.Pro1333Leu, and p.Val1769Ala). Methods: All patients presented with treatment‐resistant epilepsy in the first year of life, severe to profound intellectual disability, and in 2 cases (both with the variant p.Ile875Thr), diffuse polymicrogyria. Results: Electrophysiological recordings of mutant channels revealed prominent gain of channel function, with a markedly increased amplitude of the slowly inactivating current component, and for 2 of 3 mutants (p.Ile875Thr and p.Pro1333Leu), a leftward shift in the voltage dependence of activation to more hyperpolarized potentials. Gain of function was not observed for Nav1.3 variants known or presumed to be inherited (p.Arg1642Cys and p.Lys1799Gln). The antiseizure medications phenytoin and lacosamide selectively blocked slowly inactivating over transient current in wild‐type and mutant Nav1.3 channels. Interpretation: These findings establish SCN3A as a new gene for infantile epileptic encephalopathy and suggest a potential pharmacologic intervention. These findings also reinforce the role of Nav1.3 as an important regulator of neuronal excitability in the developing brain, while providing additional insight into mechanisms of slow inactivation of Nav1.3. Ann Neurol 2018;83:703–717

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.25188

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • 75% of patients with SCN3A GOF variants have a malformation of cortical development (MCD), such as polymicrogyria.

    “Intriguingly, 75% of patients with SCN3A GOF variants have a malformation of cortical development (MCD), such as polymicrogyria 36,37 .”

    From Developmental and epileptic encephalopathies (2024) · cites this paper as [36]

    The Discussion reports polymicrogyria in two patients with the p.Ile875Thr variant and says it was not a consistent feature of the cohort. The paper links the severe epilepsy variants to gain of function, but does not support the claimed 75% rate of cortical malformations; one of the four patients with de novo variants did not have an MRI. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zaman, T., Helbig, I., Božović, I. B., DeBrosse, S. D., Bergqvist, A. C., Wallis, K., Medne, L., Maver, A., Peterlin, B., Helbig, K. L., Zhang, X., & Goldberg, E. M.
Affiliations
  • Children's Hospital of Philadelphia (US)
  • Department of Biology and Medical Genetics, School of Medicine University of Rijeka Rijeka Croatia
  • Case Western Reserve University (US)
  • Division of Neurology, Department of Pediatrics Children's Hospital of Philadelphia Philadelphia PA
  • Division of Human Genetics, Department of Pediatrics, Individualized Medical Genetics Center Children's Hospital of Philadelphia Philadelphia PA
  • Ljubljana University Medical Centre (SI)
Corresponding author
Goldberg, Ethan M.
Venue
Annals of Neurology
Publisher
Wiley
Published
2018-03-30
Volume
83
Issue
4
Pages
703-717
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2793002335
Cited by
102
References
59
Citations by year
2026: 9 · 2025: 10 · 2024: 13 · 2023: 7 · 2022: 12 · 2021: 19 · 2020: 16 · 2019: 13 · 2018: 3
FWCI
10.03
Type
journal article
Language
en
Open access
Locations
  • Annals of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • NIH (K08 NS097633)
  • Burroughs Wellcome Fund
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
SCN3A, Nav1.3, infantile epileptic encephalopathy, voltage-gated sodium channels, de novo missense variant, gain-of-function, drug-resistant epilepsy, intellectual disability, polymicrogyria, phenytoin, lacosamide, neuronal excitability, channel pharmacology
MeSH terms
Lacosamide, Adolescent, Adult, Analysis of Variance, Cell Line, Transformed, Child, Preschool, Electric Stimulation, Female, Humans, Magnetic Resonance Imaging, Male, Membrane Potentials, Models, Molecular, Mutation, Phenytoin, Spasms, Infantile, Transfection, Sodium Channels, Cohort Studies, Patch-Clamp Techniques, Voltage-Gated Sodium Channel Blockers, NAV1.3 Voltage-Gated Sodium Channel

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review